Concepedia

Renzo Canetta

RC

40

Publications

3.1K

Citations

24

H-Index

1976

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

National Cancer Institute

University of Maryland Medical Center

University of Maryland, Baltimore

Bristol-Myers Squibb (Germany)

Renzo Canetta is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

1976–2019

40

Publications

40

Taxol: the first of the taxanes, an important new class of antitumor agents.

Eric K. Rowinsky, Nicole Onetto, Renzo Canetta et al. · PubMed · 1992 · 393 citations

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.

Duncan I. Jodrell, Merrill J. Egorin, Renzo Canetta et al. · Journal of Clinical Oncology · 1992 · 381 citations

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

Edward L. Trimble, Jascha Adams, D. Vena et al. · Journal of Clinical Oncology · 1993 · 272 citations

Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials

Lesley Stewart, Kristian Aabo, P I Adnitt et al. · 1991 · 271 citations

, , +10

Adriamycin cardiotoxicity: a survey of 1273 patients.

C Praga, G. Beretta, Vigo Pl et al. · PubMed · 1979 · 248 citations

, , +13

Rows per page

1–5 of 40